Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology

Title: Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology
Authors: Phillips, R; Basu, B; Butt, Z; Beloueche, M; Cook, N; Crabb, SJ; Greystoke, A; Hargrave, D; Jones, R; Kureeman, MY; Lopez, J; McKeeve, C; Meissner, M; O'Carrigan, B; Parkes, EE; Ronghe, M; Roxburgh, P; Sarker, D; Savage, KI; Shaw, PHS; Symeonides, S; Tweddle, DA; Vedi, A; Walter, HS; Zabkiewicz, J; Middleton, GW; Beggs, AD
Publisher Information: Springer Nature [academic journals on nature.com]
Publication Year: 2025
Collection: Oxford University Research Archive (ORA)
Description: BackgroundThe Experimental Cancer Medicine Centre (ECMC) Network supports UK-wide access to experimental cancer therapies, many of which require specific genomic alterations. This study aimed to develop expert consensus on essential genes for a pan-cancer sequencing panel, involving subject matter experts (SMEs) from the ECMC Network and the pharmaceutical industry.MethodsA pilot with 8 SMEs graded 526 genes, refining the list to 210. A three-round Delphi process was then used, with SMEs iteratively evaluating each gene. In the final round, SMEs also assessed the inclusion of tumour mutational burden (TMB), microsatellite instability (MSI), and mutation types (structural variations, copy number variations, and/or fusions).ResultsConsensus was reached on a final panel of 99 genes applicable across multiple cancers. High agreement was also achieved for including TMB, MSI, and screening for structural variations, copy number variants, and fusions. The panel is intended for both adult and paediatric tumour types.ConclusionsThis consensus-based gene panel offers a standardised approach to pan-cancer genomic screening. It supports harmonised diagnostics and could improve patient access to personalised therapies and research trials across clinical and NHS settings.
Document Type: article in journal/newspaper
Language: English
DOI: 10.1038/s41416-025-03252-6
Availability: https://doi.org/10.1038/s41416-025-03252-6; https://ora.ox.ac.uk/objects/uuid:0876f4d7-d5fc-4547-b208-f4da0c8fdc48
Rights: info:eu-repo/semantics/openAccess ; CC Attribution (CC BY)
Accession Number: edsbas.6B4BD9C8
Database: BASE